Core Viewpoint - BWX Technologies reported strong Q3 earnings, beating analyst expectations, yet the stock price declined due to high valuation concerns [1][7]. Financial Performance - BWX Technologies earned $1 per share (non-GAAP) against an analyst forecast of $0.86, with sales reaching $866.3 million compared to the expected $796.6 million [1][2]. - The GAAP earnings were $0.89 per share, reflecting a 17% year-over-year increase [2]. Growth Indicators - CEO Rex Geveden highlighted double-digit organic revenue growth and a significant backlog increase of 119% year-over-year, totaling $7.4 billion [3]. - The company raised its guidance, predicting earnings between $3.75 and $3.80 (non-GAAP) for the year [4]. Market Context - The demand for nuclear solutions in defense, clean energy, and medical markets is described as unprecedented, positioning the company for strong future sales [4]. - Despite positive earnings and guidance, the stock is considered overvalued at nearly 54 times current year earnings, leading to a recommendation to sell [5][7].